Feng Chi Biotech Corp. 6744.TWO Stock
23.65 TWD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Taiwan
Exchange
Taipei Exchange
Market Cap
364.21M TWD
LOW - HIGH [24H]
23.65
-
23.65 TWD
VOLUME [24H]
6 TWD
{{ volume }}
P/E Ratio
16.08
Earnings per share
1.47 TWD
Feng Chi Biotech Corp. Price Chart
Feng Chi Biotech Corp. 6744.TWO Financial and Trading Overview
| Feng Chi Biotech Corp. stock price | 23.65 TWD |
| Previous Close | 25.9 TWD |
| Open | 26.85 TWD |
| Bid | 25.85 TWD x N/A |
| Ask | 26.95 TWD x N/A |
| Day's Range | 25.85 - 26.95 TWD |
| 52 Week Range | 18 - 32.75 TWD |
| Volume | 74.15K TWD |
| Avg. Volume | 27.24K TWD |
| Market Cap | 415.03M TWD |
| Beta (5Y Monthly) | 0.034172 |
| PE Ratio (TTM) | 16.333334 |
| EPS (TTM) | 1.47 TWD |
| Forward Dividend & Yield | 1.25 (4.82%) |
| Ex-Dividend Date | July 4, 2022 |
| 1y Target Est | N/A |
6744.TWO Valuation Measures
| Enterprise Value | 176.83M TWD |
| Trailing P/E | 16.333334 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.1453013 |
| Price/Book (mrq) | 1.7595979 |
| Enterprise Value/Revenue | 0.914 |
| Enterprise Value/EBITDA | 5.766 |
Trading Information
Feng Chi Biotech Corp. Stock Price History
| Beta (5Y Monthly) | 0.034172 |
| 52-Week Change | 15.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.75 TWD |
| 52 Week Low | 18 TWD |
| 50-Day Moving Average | 27.35 TWD |
| 200-Day Moving Average | 21.85 TWD |
6744.TWO Share Statistics
| Avg. Volume (3 month) | 27.24K TWD |
| Avg. Daily Volume (10-Days) | 29.74K TWD |
| Shares Outstanding | 15.4M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.35 |
| Trailing Annual Dividend Yield | 5.21% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.78129995 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.72% |
| Operating Margin (ttm) | 13.99% |
| Gross Margin | 43.13% |
| EBITDA Margin | 15.85% |
Management Effectiveness
| Return on Assets (ttm) | 5.68% |
| Return on Equity (ttm) | 10.55% |
Income Statement
| Revenue (ttm) | 193.46M TWD |
| Revenue Per Share (ttm) | 12.56 TWD |
| Quarterly Revenue Growth (yoy) | 7.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | 30.67M TWD |
| Net Income Avi to Common (ttm) | 24.61M TWD |
| Diluted EPS (ttm) | 1.65 |
| Quarterly Earnings Growth (yoy) | 44.39% |
Balance Sheet
| Total Cash (mrq) | 235.41M TWD |
| Total Cash Per Share (mrq) | 15.29 TWD |
| Total Debt (mrq) | 13.38M TWD |
| Total Debt/Equity (mrq) | 5.67 TWD |
| Current Ratio (mrq) | 4.473 |
| Book Value Per Share (mrq) | 15.316 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 28.49M TWD |
| Levered Free Cash Flow (ttm) | 24.2M TWD |
Profile of Feng Chi Biotech Corp.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | 1, No.5, Shaoxing North Street |
| ZIP | 100 |
| Phone | 886 2 2351 9800 |
| Website | https://www.fcbiotech.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Feng Chi Biotech Corp. provides preimplantation genetic testing, prenatal testing, life science, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services. It also distributes various genetic testing technologies and products in oncology. The company is based in Taipei, Taiwan.
Q&A For Feng Chi Biotech Corp. Stock
What is a current 6744.TWO stock price?
Feng Chi Biotech Corp. 6744.TWO stock price today per share is 23.65 TWD.
How to purchase Feng Chi Biotech Corp. stock?
You can buy 6744.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Feng Chi Biotech Corp.?
The stock symbol or ticker of Feng Chi Biotech Corp. is 6744.TWO.
Which industry does the Feng Chi Biotech Corp. company belong to?
The Feng Chi Biotech Corp. industry is Biotechnology.
How many shares does Feng Chi Biotech Corp. have in circulation?
The max supply of Feng Chi Biotech Corp. shares is 15.4M.
What is Feng Chi Biotech Corp. Price to Earnings Ratio (PE Ratio)?
Feng Chi Biotech Corp. PE Ratio is 16.08843400 now.
What was Feng Chi Biotech Corp. earnings per share over the trailing 12 months (TTM)?
Feng Chi Biotech Corp. EPS is 1.47 TWD over the trailing 12 months.
Which sector does the Feng Chi Biotech Corp. company belong to?
The Feng Chi Biotech Corp. sector is Healthcare.